NCT Number: NCT05617040
Phase: Phase 1|Phase 2
Trial Summary: This is a multi-centre, Phase 1/2, open-label clinical trial of the VTP-850 prime-boost immunotherapeutic in men with biochemical recurrence after definitive local therapy for pros – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Barinthus Biotherapeutics
Acronym:
Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives